Zakrowski Donald A 4
4 · ELI LILLY & Co · Filed Mar 11, 2024
Insider Transaction Report
Form 4
Zakrowski Donald A
SVP, Finance, & CAO
Transactions
- Sale
Common Stock
2024-03-11$753.60/sh−750$565,200→ 7,880 total - Award
Restricted Stock Unit
2024-02-12+184→ 184 totalFrom: 2026-02-16Exp: 2026-02-16→ Common Stock (184 underlying) - Award
Restricted Stock Unit
2024-02-12+186→ 186 totalFrom: 2027-02-16Exp: 2027-02-16→ Common Stock (186 underlying)
Holdings
- 1,710(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024.